2000-2018年威尔士基底细胞癌的流行病学、医疗与社会负担:一项回顾性全国分析
BACKGROUND: Basal cell carcinoma (BCC) represents the most commonly occurring cancer worldwide within the white population. Reports predict 298 308 cases of BCC in the UK by 2025, at a cost of £265-366 million to the National Health Service (NHS).…
要点
- 2018年威尔士基底细胞癌欧洲年龄标化发病率为224.6/10万人年。
- 2016-2018年SBUHB病理数据较SAIL匹配区域发病率高45%。
核心结论
- 研究首次展示威尔士基底细胞癌发病率,为英国和欧洲已发表最高发病率之一。
研究设计与样本
- 回顾性全国分析,链接SAIL数据银行2000-2018年癌症登记与常规医疗数据库,并以SBUHB病理数据内部验证。
主要发现
- 研究期间SAIL数据银行共识别61404例组织学确诊基底细胞癌。
- 2018年基底细胞癌欧洲年龄标化发病率为224.6/10万人年。
- 2016-2018年SBUHB病理数据较SAIL匹配区域发病率高45%。
- 贫困与发病率呈负相关,最不贫困者和农村居民发病率更高。
- 约2%患者为皮肤科服务出行25-50英里,而整形外科为37%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Basal cell carcinoma (BCC) represents the most commonly occurring cancer worldwide within the white population. Reports predict 298 308 cases of BCC in the UK by 2025, at a cost of £265-366 million to the National Health Service (NHS). Despite the morbidity, societal and healthcare pressures brought about by BCC, routinely collected healthcare data and global registration remain limited. OBJECTIVES: To calculate the incidence of BCC in Wales between 2000 and 2018 and to establish the related healthcare utilization and estimated cost of care. METHODS: The Secure Anonymised Information Linkage (SAIL) databank is one of the largest and most robust health and social care data repositories in the UK. Cancer registry data were linked to routinely collected healthcare databases between 2000 and 2018. Pathological data from Swansea Bay University Health Board (SBUHB) were used for internal validation. RESULTS: A total of 61 404 histologically proven BCCs were identified within the SAIL Databank during the study period. The European age-standardized incidence for BCC in 2018 was 224.6 per 100 000 person-years. Based on validated regional data, a 45% greater incidence was noted within SBUHB pathology vs. matched regions within SAIL between 2016 and 2018. A negative association between deprivation and incidence was noted with a higher incidence in the least socially deprived and rural dwellers. Approximately 2% travelled 25-50 miles for dermatological services compared with 37% for plastic surgery. Estimated NHS costs of surgically managed lesions for 2002-2019 equated to £119.2-164.4 million. CONCLUSIONS: Robust epidemiological data that are internationally comparable and representative are scarce for nonmelanoma skin cancer. The rising global incidence coupled with struggling healthcare systems in the post-COVID-19 recovery period serve to intensify the societal and healthcare impact. This study is the first to demonstrate the incidence of BCC in Wales and is one of a small number in the UK using internally validated large cohort datasets. Furthermore, our findings demonstrate one of the highest published incidences within the UK and Europe.
引用
- Ibrahim N, Jovic M, Ali S, et al. The epidemiology, healthcare and societal burden of basal cell carcinoma in Wales 2000-2018: a retrospective nationwide analysis. Br J Dermatol. 2023. PMID: 36715329. doi:10.1093/bjd/ljac090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。